Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0HS3M
|
||||
| Former ID |
DNC013569
|
||||
| Drug Name |
1-(1-(pyrazin-2-yl)ethylidene)thiosemicarbazide
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C7H9N5S
|
||||
| Canonical SMILES |
CC(=NNC(=S)N)C1=NC=CN=C1
|
||||
| InChI |
1S/C7H9N5S/c1-5(11-12-7(8)13)6-4-9-2-3-10-6/h2-4H,1H3,(H3,8,12,13)/b11-5-
|
||||
| InChIKey |
LNRWBLGPWCJQEM-WZUFQYTHSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Tyrosine oxidase | Target Info | Inhibitor | [1] | |
| BioCyc Pathway | (S)-reticuline biosynthesis | ||||
| Eumelanin biosynthesis | |||||
| L-dopachrome biosynthesis | |||||
| KEGG Pathway | Tyrosine metabolism | ||||
| Riboflavin metabolism | |||||
| Metabolic pathways | |||||
| Melanogenesis | |||||
| PathWhiz Pathway | Riboflavin Metabolism | ||||
| Tyrosine Metabolism | |||||
| WikiPathways | Dopamine metabolism | ||||
| References | |||||
| REF 1 | Bioorg Med Chem. 2008 Feb 1;16(3):1096-102.1-(1-Arylethylidene)thiosemicarbazide derivatives: a new class of tyrosinase inhibitors. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.